Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6200.00 | 6543.00 | 0.9476 | 0.9294 | |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 5566.00 | 6543.00 | 0.8507 | 0.7955 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6288.00 | 6543.00 | 0.9610 | 0.9477 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 5000.00 | 2314.91 | 5393.00 | 6543.00 | 0.8242 | 0.7580 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 5000.00 | 2314.91 | 6531.00 | 6543.00 | 0.9982 | 0.9976 |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 5000.00 | 2314.91 | 6242.00 | 6543.00 | 0.9540 | 0.9381 |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6709.00 | 6543.00 | 1.0254 | 1.0337 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6776.00 | 6543.00 | 1.0356 | 1.0472 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6765.00 | 6543.00 | 1.0339 | 1.0450 | |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 6498.00 | 6543.00 | 0.9931 | 0.9908 |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 5000.00 | 2314.91 | 7024.00 | 6543.00 | 1.0735 | 1.0969 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6810.00 | 6543.00 | 1.0408 | 1.0541 | |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 5000.00 | 2314.91 | 6286.00 | 6543.00 | 0.9607 | 0.9472 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6701.00 | 6543.00 | 1.0241 | 1.0321 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 5000.00 | 2314.91 | 5889.00 | 6543.00 | 0.9001 | 0.8643 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 5000.00 | 2314.91 | 4248.00 | 6543.00 | 0.6492 | 0.4993 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6651.00 | 6543.00 | 1.0165 | 1.0220 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6716.00 | 6543.00 | 1.0264 | 1.0351 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 5000.00 | 2314.91 | 6713.00 | 6543.00 | 1.0260 | 1.0345 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6341.00 | 6543.00 | 0.9691 | 0.9586 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6543.00 | 6543.00 | 1.0000 | 1.0000 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6530.00 | 6543.00 | 0.9980 | 0.9974 | |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 195.00 | 231.00 | 0.8442 | 0.8188 | |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 156.25 | 67.09 | 228.00 | 231.00 | 0.9870 | 0.9854 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 224.00 | 231.00 | 0.9697 | 0.9658 |